You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com | |
Most viewed
- 1. Upregulation of miR-183 inhibits the invasion and migration of endometrial stromal cells in endometriosis patients by downregulating Ezrin
- 2. Accord Healthcare receives approval for Hetronifly® (Serplulimab), from the Medicines and Healthcare Regulatory Agency (MHRA) for first-line treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
- 3. Your CT scan could reveal a hidden heart risk—and AI just learned how to find it
- 4. Neoadjuvant chemotherapy with or without metformin in early-stage or locally advanced (non-metastatic) triple negative breast cancer—an open-label phase 2 randomized controlled trial
- 5. Machine learning-based preoperative prediction of perioperative venous thromboembolism in Chinese lung cancer patients: a retrospective cohort study
- 6. Vaccine therapies for glioma: clinical frontiers and potential breakthrough
- 7. Rare metastasis of the urinary bladder from esophageal squamous cell carcinoma: a case report
- 8. CHMP6 as a novel prognostic biomarker in bladder cancer: insights from a comprehensive cell death-related gene risk model
- 9. Untargeted metabolomics revealed urinary metabolic pattern for discriminating prostate cancer from benign prostatic hyperplasia in Chinese participants
- 10. Exploration of the role and mechanism of Rhizoma Paridis total saponins in osteosarcoma based on SPI1/LCN2-mediated ferroptosis
Last updated at 23:26 GMT
Hot News Makers
Health/Pharma Companies
- 108038.57
- 20353.12
- 16407.28
- 16147.33
- 14741.61
- 11712.17
- 11096.04
- 10439.11
- 8640.88
- 7973.69
Drugs, Treatments, Trials
- 211833.06
- 38510.74
- 6963.02
- 6348.64
- 5216.94
- 4107.04
- 3053.05
- 3038.36
- 2458.55
- 2400.03
Last updated at 23:10 GMT
